Event: ELCC 2021

0:01:45

Targeting RET in lung cancer

0:10:54

Dr Sachin Gupta | Management of NSC Lung Cancer ELCC Updates

0:09:16

Lung cancer screening: NELSON and NLST

0:02:47

Update from a phase 1 study of AMG 757 in SCLC

0:01:43

Novel targets for NSCLC

0:02:37

Upfront treatment of ROS1-rearranged NSCLC

0:01:33

Real-world experience of Impower150 regimen for EGFR+ NSCLC

0:04:50

COVID-19: impact on lung cancer treatment in the UK

0:02:50

Immunotherapy updates from WCLC 2021

2:29:37

CPUC Workshop on IRP Mid-term Reliability Analysis and Proposed Procurement (Mar. 10, 2021)

0:02:42

Lung cancer trial updates at ASCO 2021

0:01:21

NICE approval of brigatinib in ALK-positive NSCLC

0:03:05

Managing the IMpower 150 Regimen in Nonsquamous mNSCLC

1:02:29

Email writing skills- Contact class

0:07:09

Cemiplimab plus ipilimumab for advanced NSCLC

0:02:55

Limitations of genetic testing for actionable mutations in lung cancer

0:05:37

Surgery for oligometastatic lung cancer

0:28:21

NW/MET, NWeLearn, and eLCC Organizational Speed Dating and Awards Ceremony

0:03:04

TERAVOLT: outcomes for patients with COVID-19 and lung cancer

0:02:20

Patterns of relapse after radiotherapy in SCLC and future treatment strategies

0:04:23

Management of patients with PDL1-high advanced NSCLC

0:02:40

Treating cancer during the COVID-19 pandemic

0:03:09

Roy Castle Lung Cancer: genomics and novel risk models

2:57:46

The 2022 OncoAlert Colloquium DAY 3: Lung Cancer